142
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Polymorphisms in the K13-Propeller Gene in Artemisinin-Resistant Plasmodium in Mice

, , , , , , , , , , , , , , & show all
Pages 6533-6544 | Received 26 Jul 2022, Accepted 26 Oct 2022, Published online: 08 Nov 2022

References

  • World Health Organization. Guidelines for the Treatment of Malaria. World Health Organization; 2010.
  • White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330–334. doi:10.1126/science.1155165
  • World Health Organization. World Malaria Report 2020. Geneva: World Health Organization; 2020.
  • Ariey F, Witkowski B, Amaratunga C, et al. molecular marker of artemisinin -resistant Plasmodium falciparum malaria. Nature. 2014;2:e12876.
  • Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin resistant malaria in western Cambodia. N Eng J Med. 2008;359:2619–2620. doi:10.1056/NEJMc0805011
  • Arjen M. Dondorp, François Nosten, Poravuth Yi, Debashish Das, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Eng J Med. 2009;361:455–467. doi:10.1056/NEJMoa0808859
  • Anderson TJ, Nair S, Nkhoma S, et al. High Heritability of Malaria Parasite Clearance Rate Indicates a Genetic Basis for Artemisinin Resistance in Western Cambodia. Brief Report. 2010;201(1):1326–1330.
  • Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505(7481):50–55. doi:10.1038/nature12876
  • Wang J, Xu C, Liao FL, et al. Solution to “Artemisinin Resistance”. N Engl J Med. 2019;380(22):2087–2089. doi:10.1056/NEJMp1901233
  • Witkowski B, Amaratunga C, Khim N, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis. 2013;13(12):1043–1049. doi:10.1016/S1473-3099(13)70252-4
  • WWARN K13 Genotype-Phenotype Study Group. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments a WWARN individual patient data meta-analysis. BMC Med. 2019;17(1):548. doi:10.1186/s12916-018-1207-3
  • Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–55.
  • World Health Organisation. Global Malaria Programme. Status Report on Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy. Geneva: The Organisation; 2018.
  • Peters W. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, part 1: which model is appropriate? Ann Trop Med Parasitol. 1999;93(6):569–587. doi:10.1080/00034983.1999.11813461
  • Wykes MN, Michael F. Infectious disease: malaria What have we learnt from mouse models for the study of malaria? Eur J Immunol. 2009;39:1991–2058. doi:10.1002/eji.200939552
  • Kiboi DM, Irungu BN, Langat B, et al. Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model. Exp Parasitol. 2009;122:196–202. doi:10.1016/j.exppara.2009.03.010
  • Peters W. Chemotherapy and Drug Resistance in Malaria. New York, NY: Academic Press; 1970.
  • Merkli B, Richie R, Peters W. The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Ann trop Med Parasit. 1980;74:1–9. doi:10.1080/00034983.1980.11687304
  • Peters W. Drug resistance in Plasmodium berghei, Vincke and Lips. 1948.1. Chloroquine resistance. Exp Parasit. 1965;17:80–89. doi:10.1016/0014-4894(65)90012-3
  • Peters W. Drug resistance in Plasmodium berghei, Vincke and Lips. 1948.1. Chloroquine resistance. Exp Parasit. 1965;17:80–89.
  • Ndung’u L, Langat B, Magiri E, et al. Amodiaquine resistance in Plasmodium berghei is associated with PbCRT His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters. Wellcome Open Res. 2017;2:44. doi:10.12688/wellcomeopenres.11768.1
  • Birnbaum J, Scharf S, Schmidt S, et al. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites. Science. 2020;367(6473):51–59. doi:10.1126/science.aax4735
  • Wang J. Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation. PLoS One. 2010;5:12.
  • Yeast Model LW. Uncovers Dual Roles of Mitochondria in the Action of Artemisinin. PLo S Genet. 2005;1:e36. doi:10.1371/journal.pgen.0010036
  • Bunditvorapoom D, Kochakarn T, Kotanan N, et al. Fitness Loss under Amino Acid Starvation in Artemisinin-Resistant Plasmodium falciparum Isolates from Cambodia. Sci Rep. 2018;8(1):12622. doi:10.1038/s41598-018-30593-5
  • Elfawal MA, Towler MJ, Reich NG, Weathers PJ, Rich SM. Dried whole-plant Artemisia annua slows evolution of malaria drug resistance and overcomes resistance to artemisinin. Proc Natl Acad Sci U S A. 2015;112(3):821–826. doi:10.1073/pnas.1413127112
  • De Lucia S, Tsamesidis I, Pau MC, Kesely KR, Pantaleo A, Turrini F. Induction of high tolerance to artemisinin by sub-lethal administration: a new in vitro model of P. falciparum. PLoS One. 2018;13(1):e0191084. doi:10.1371/journal.pone.0191084
  • Cerqueira GC, Cheeseman IH, Schaffner SF, et al. Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance. Genome Biol. 2017;18(1):78. doi:10.1186/s13059-017-1204-4
  • Nguetse CN, Adegnika AA, Agbenyega T, et al. Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria. Malar J. 2017;16(1):217. doi:10.1186/s12936-017-1868-y
  • Tumwebaze P, Tukwasibwe S, Taylor A, et al. Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda. J Infect Dis. 2017;215(4):631–635. doi:10.1093/infdis/jiw614
  • Guerra M, Neres R, Salgueiro P, et al. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy. Antimicrob Agents Chemother. 2016;61(1):e02556–15. doi:10.1128/AAC.02556-15
  • St Laurent B, Miller B, Burton TA, et al. Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa. Nat Commun. 2015;6:8614. doi:10.1038/ncomms9614
  • Paloque L, Witkowski B, Lelièvre J, et al. Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism. J Antimicrob Chemother. 2018;73(2):395–403. doi:10.1093/jac/dkx412
  • Mbengue A, Bhattacharjee S, Pandharkar T, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520(7549):683–687. doi:10.1038/nature14412
  • Bhattacharjee S, Coppens I, Mbengue A, et al. Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance. Blood. 2018;131(11):1234–1247. doi:10.1182/blood-2017-11-814665
  • Birnbaum J, Scharf S, Schmidt S, et al. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites. Science. 2020;367(6473):51–59.
  • Pholwat S, Liu J, Stroup S, et al. The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction. Antimicrob Agents Chemother. 2017;61(5):e00110–17. doi:10.1128/AAC.00110-17
  • Nag S, Dalgaard MD, Kofoed PE, et al. High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing -technology. Sci Rep. 2017;7(1):2398. doi:10.1038/s41598-017-02724-x